Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Enalapril, Losartan or Not Antihypertensive on the Oxidative Status in Renal Transplant Recipients

NCT05232370 is registered in ClinicalTrials.gov with Unidad de Investigacion Medica en Enfermedades Renales as lead sponsor.

NCT NCT05232370
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05232370 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Enalapril, Losartan or Not Antihypertensive on the Oxidative Status in Renal Transplant Recipients
Lead sponsor
Unidad de Investigacion Medica en Enfermedades Renales
Phase
Phase 2
Overall status
Completed
Start date
January 1, 2022
Completion date
January 6, 2022
Enrollment
39 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

oxidative stress